Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Debt Ratio (2021 - 2026)

Centessa Pharmaceuticals has reported Debt Ratio over the past 5 years, most recently at 0.16 for Q4 2025.

  • Quarterly Debt Ratio fell 15.21% to 0.16 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.16 through Dec 2025, down 15.21% year-over-year, with the annual reading at 0.16 for FY2025, 15.21% down from the prior year.
  • Debt Ratio was 0.16 for Q4 2025 at Centessa Pharmaceuticals, down from 0.24 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.24 in Q3 2025 and troughed at 0.12 in Q4 2021.
  • The 5-year median for Debt Ratio is 0.19 (2023), against an average of 0.18.
  • Year-over-year, Debt Ratio tumbled 36.69% in 2024 and then soared 97.3% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.12 in 2021, then skyrocketed by 30.67% to 0.16 in 2022, then surged by 33.76% to 0.21 in 2023, then decreased by 10.12% to 0.19 in 2024, then fell by 15.21% to 0.16 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Debt Ratio are 0.16 (Q4 2025), 0.24 (Q3 2025), and 0.22 (Q2 2025).